ACCUM-002 Trademark

Trademark Overview


On Monday, August 28, 2023, a trademark application was filed for ACCUM-002 with the United States Patent and Trademark Office. The USPTO has given the ACCUM-002 trademark a serial number of 98154157. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, August 19, 2024. This trademark is owned by Defence Therapeutics Inc.. The ACCUM-002 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Drug delivery agents consisting of intracellular enhancers in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals; medicinal preparations for use in oncology; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; vaccines for human use

Antibody testing, namely, antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of oncology
accum-002

General Information


Serial Number98154157
Word MarkACCUM-002
Filing DateMonday, August 28, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDrug delivery agents consisting of intracellular enhancers in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals; medicinal preparations for use in oncology; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; vaccines for human use
Pseudo MarkACCUM ZERO ZERO TWO
Goods and ServicesAntibody testing, namely, antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of oncology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 26, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 26, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDefence Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, B.C. V6C3L6
CA

Trademark Events


Event DateEvent Description
Tuesday, September 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 31, 2023NEW APPLICATION ENTERED
Tuesday, April 23, 2024ASSIGNED TO EXAMINER
Thursday, April 25, 2024NON-FINAL ACTION WRITTEN
Thursday, April 25, 2024NON-FINAL ACTION E-MAILED
Thursday, April 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 16, 2024ASSIGNED TO EXAMINER
Monday, August 19, 2024LETTER OF SUSPENSION E-MAILED
Monday, August 19, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 19, 2024SUSPENSION LETTER WRITTEN